PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-12

Date Title Company
12-May-2026 JAMS Launches ADR Technology Industry Group Businesswire
12-May-2026 ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update Businesswire
12-May-2026 Skylark Bio to Present New Preclinical Data for its Pendrin Gene Therapy Program for Hearing Loss at ASGCT 2026 Businesswire
12-May-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-May-2026 Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress Businesswire
12-May-2026 bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 Businesswire
12-May-2026 Tenon(R) Medical Reports First Quarter 2026 Financial Results ACCESS Newswire
12-May-2026 New Data: LifeVest® Wearable Defibrillator is Useful Tool for Quicker Beta-Blocker Optimization in Women Businesswire
12-May-2026 MMS Strengthens Science-Led Global Leadership, Naming Ben Dudley as President Businesswire
12-May-2026 EnPlusOne Biosciences Highlights Significant Advancements to its ezRNA™ Enzymatic RNA Synthesis Platform and Introduces Novel Modifications for Next-Generation RNA Therapeutics Businesswire
12-May-2026 Virta Health’s Nutrition-Based Care Demonstrates Broad, Sustained Reductions in Chronic Inflammation Businesswire
12-May-2026 ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions Businesswire
12-May-2026 Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market Businesswire
12-May-2026 Introducing Cognite Flows™: The First Fully Integrated, AI-Native Industrial Experience that Accelerates Customer Value Businesswire
12-May-2026 Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance Businesswire
12-May-2026 Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference Businesswire
12-May-2026 Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity Businesswire
12-May-2026 Quantitative Biosciences Institute Appoints John A.T. Young, Ph.D., as Chief Strategy Officer Businesswire
12-May-2026 Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update Businesswire
12-May-2026 Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Businesswire